Obdulia Rabal

Pamplona, NC 31008, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.

Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.

Journal: Nature communications

Published: February 02, 2023

A toolkit for covalent docking with GOLD: from automated ligand preparation with KNIME to bound protein-ligand complexes.

A toolkit for covalent docking with GOLD: from automated ligand preparation with KNIME to bound protein-ligand complexes.

Journal: Bioinformatics advances

Published: May 16, 2022

Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.

Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: November 03, 2021

Fine tuning for success in structure-based virtual screening.

Fine tuning for success in structure-based virtual screening.

Journal: Journal of computer-aided molecular design

Published: July 09, 2021

Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.

Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.

Journal: Journal of medicinal chemistry

Published: March 04, 2021

Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles.

Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles.

Journal: ACS chemical neuroscience

Published: August 24, 2019

Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach.

Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach.

Journal: Journal of computer-aided molecular design

Published: August 06, 2019

A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity.

A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity.

Journal: Cancer letters

Published: July 22, 2019

Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer's Disease.

Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer's Disease.

Journal: Frontiers in aging neuroscience

Published: March 25, 2019

Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors.

Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors.

Journal: ACS chemical neuroscience

Published: December 12, 2018

Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors.

Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors.

Journal: European journal of medicinal chemistry

Published: November 14, 2018

Development and Validation of Molecular Overlays Derived from Three-Dimensional Hydrophobic Similarity with PharmScreen.

Development and Validation of Molecular Overlays Derived from Three-Dimensional Hydrophobic Similarity with PharmScreen.

Journal: Journal of chemical information and modeling

Published: July 17, 2018

Showing 1-12 of 48

Last Updated: 09/26/2026